| Floor Price | ₹771.73Per Equity Share |
|---|---|
| Market Cap | ₹31,156.82 CrLarge Cap |
| Revenue TTM | ₹3,904.6 CrOperating |
| RSI | 56.17Neutral Zone |
Key highlights
- Floor price for the QIP set at ₹771.73 per equity share based on SEBI ICDR regulations
- Company may offer a discretionary discount of up to 5% on the calculated floor price
- Issue officially opened on June 16, 2026, following a Finance and Investment Committee meeting
- Capital raise follows shareholder approval granted via postal ballot on April 15, 2026
- A committee meeting is scheduled for June 19, 2026, to finalize the specific issue price
What Is the Fund Raise?
Krishna Institute of Medical Sciences Limited has commenced a Qualified Institutions Placement of equity shares with a face value of ₹2 each. The company's Finance and Investment Committee authorized the opening of the issue on June 16, 2026, adopting the preliminary placement document on the same date. The floor price has been fixed at ₹771.73 per share, though the company retains the discretion to offer a discount of up to 5% in consultation with book running lead managers.
This capital-raising exercise follows a special resolution passed by members via postal ballot on April 15, 2026.
Strategic Rationale
This QIP marks a significant step in the capital management strategy for KIMS, intended to provide the necessary liquidity for its multi-state expansion plans. By tapping into institutional investors, the hospital chain aims to optimize its balance sheet and support ongoing capital expenditure without over-leveraging. The timing aligns with efforts to deepen its footprint beyond its core markets in Telangana and Andhra Pradesh into high-growth regions like Maharashtra.
The pricing reflects current market valuations where KIMS has maintained a trailing twelve-month price-to-earnings ratio of 129.07.
Business Overview
- KIMS operates as one of the largest corporate healthcare groups in South India by number of beds
- The company provides multi-disciplinary healthcare services including cardiac sciences, oncology, and neurosciences
- Operations are primarily concentrated in Andhra Pradesh and Telangana with strategic entries into Maharashtra
- The group focuses on an affordable, high-quality healthcare delivery model across tier-1 and tier-2 cities
Financial Context
KIMS reported an annual operating revenue of ₹3,904.6 crore for the most recent fiscal year, showcasing a growth rate of 28.16% year-on-year. Despite recent fluctuations in quarterly net profit, the company maintains a Piotroski score of 4 and a durability score of 35. The current market capitalization stands at ₹31,156.82 crore, with the stock trading near its one-year high of ₹811.
The influx of institutional capital through this QIP is expected to strengthen the company net worth, which currently supports a Return on Equity of 10.74%.
Industry Context
- Indian healthcare facilities are experiencing rapid consolidation as larger chains acquire standalone regional hospitals
- Rising demand for specialized medical services is driving capital expenditure across the private hospital sector
- Listed hospital peers are increasingly utilizing QIPs to fund greenfield and brownfield expansion projects
- Increasing insurance penetration is improving revenue predictability for organized healthcare providers in India
| Share price | ₹778.65 |
|---|---|
| Market capitalisation | ₹31,156.82 Cr |
| Revenue (annual) | ₹3,904.60 Cr |
| Net profit (annual) | ₹241.40 Cr |
| Revenue (latest quarter) | ₹1,074.60 Cr+7.71% vs previous quarter |
| Net profit (latest quarter) | ₹42.50 Cr-20.41% vs previous quarter |
| P/E (TTM) | 129.07×Sector 61.59× |
| Promoter holding | 34.11%0.00% QoQ |
| FII holding | 14.57%Current quarter |
Reference market data from a third-party provider, as of the story. Not a valuation or a recommendation.
Exchange filing by Krishna Institute of Medical Sciences Limited announcing the opening of its Qualified Institutions Placement. Market figures from a third-party data provider.
